NASDAQ:AXGT - Axovant Gene Therapies Earnings Date, Estimates & History

+0.27 (+5.57 %)
(As of 06/17/2019 03:23 AM ET)
Today's Range
Now: $5.12
50-Day Range
MA: $5.40
52-Week Range
Now: $5.12
Volume714,205 shs
Average Volume480,558 shs
Market Capitalization$116.63 million
P/E RatioN/A
Dividend YieldN/A


Axovant Gene Therapies (NASDAQ:AXGT) Earnings History and Estimates Chart

Earnings by Quarter for Axovant Gene Therapies (NASDAQ:AXGT)

Axovant Gene Therapies (NASDAQ:AXGT) Earnings Estimates

2019 EPS Consensus Estimate: ($0.19)
2020 EPS Consensus Estimate: ($3.48)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20192($0.21)($0.16)($0.19)
Q1 20201($0.70)($0.70)($0.70)
Q2 20201($0.84)($0.84)($0.84)
Q3 20201($0.98)($0.98)($0.98)
Q4 20201($0.96)($0.96)($0.96)

Axovant Gene Therapies (NASDAQ AXGT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/11/2019Q4($1.6980)($0.45)($0.45)ViewN/AView Earnings Details
2/7/2019Q3 2019($2.16)($2.16)($0.27)ViewN/AView Earnings Details
11/7/2018Q2 2019($3.04)($2.24)($0.28)ViewN/AView Earnings Details
8/7/2018Q1 2019($1.28)($3.84)($0.48)ViewN/AView Earnings Details
6/11/2018Q4 2018($2.80)($1.84)($0.23)ViewN/AView Earnings Details
2/9/2018Q3 2018($4.32)($0.54)ViewN/AView Earnings Details
11/2/2017Q2 2018($4.40)($5.12)($0.64)ViewN/AView Earnings Details
8/7/2017Q1 2018($4.16)($5.20)($0.65)ViewN/AView Earnings Details
6/13/2017Q4 2017($4.08)($4.24)($0.53)ViewN/AView Earnings Details
2/14/2017Q3 2017($3.60)($3.84)($0.48)ViewN/AView Earnings Details
11/7/2016Q2 2017($3.20)($3.44)($0.43)ViewN/AView Earnings Details
8/15/2016Q1 2017($2.96)($3.04)($0.38)ViewN/AView Earnings Details
6/6/2016Q4 2016($1.92)($2.40)($0.30)ViewN/AView Earnings Details
2/9/2016Q3 2016($1.20)($5.12)($0.64)ViewN/AView Earnings Details
11/2/2015Q2 2016($1.20)($0.96)($0.12)ViewN/AView Earnings Details
8/11/2015Q1 2016($0.80)($2.80)($0.35)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/17/2019 by Staff

Featured Article: Risk Tolerance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel